Investigators evaluated whether a modular, transdiagnostic cognitive-behavioral program—Modular Anxiety Skills Training (MAST)—would outperform standard Primary Care Behavioral Health (PCBH) treatment as usual (TAU) when both are delivered by frontline clinicians in primary care. The trial was multi-site and randomized. The reported aim was to compare effects on anxiety severity and impairment; the study team recruited patients from two Veterans Health Administration (VHA) systems to test real-world feasibility in primary care settings. The source did not provide itemized session counts, modular components, or dosing schedules in the abstract; those procedural details were not reported there.
The study used the Overall Anxiety Severity and Impairment Scale (OASIS) as a core outcome. Investigators also reported anxiety and depression symptom severity, measures of functional disability, and quality of life. The abstract states intent-to-treat analyses at 16 weeks post-treatment as the primary comparative timepoint. The authors reported effect-size estimates for within-group changes, with a range cited as small-to-medium (0.21–0.61) for the outcomes summarized in the abstract.
The randomized cohort comprised 167 participants recruited from primary care at two VHA health systems. Demographics reported in the abstract: 70% male, 89% White, 9% Hispanic, and mean age 51 years (SD 16). Investigators positioned the sample within a Veterans primary-care population; the abstract did not include additional demographic breakdowns, comorbidity rates beyond depression moderating analyses, or detailed inclusion and exclusion criteria.
Intent-to-treat analyses at the 16-week post-treatment assessment found no superiority for MAST over PCBH TAU on primary outcomes. The cohort in both arms improved significantly on anxiety severity and impairment (OASIS), on anxiety and depression symptom scales, and on measures of functional disability and quality of life. Effect sizes for those within-group improvements were reported as small-to-medium. The trial included a 28-week follow-up assessment. At that later timepoint, all gains were maintained across groups, and participants who received MAST demonstrated further significant reduction on the OASIS between post-treatment and follow-up.
Post hoc analyses reported by the study team suggested that baseline depression severity moderated treatment response. Specifically, participants with moderate and severe comorbid depression showed greater benefit from MAST compared with PCBH TAU in these exploratory analyses. The abstract frames these moderator results as post hoc and therefore hypothesis-generating; investigators cautioned that prospective replication is required before clinical recommendations should change based on this signal.
The authors noted that comparing a manualized, modular CBT approach to an active PCBH behavioral-treatment comparison represents a strong methodological test in primary care. They argued that MAST may offer implementation advantages because it is manualized and modular, attributes that can support training, fidelity, and flexible tailoring in busy primary care behavioral health teams. The abstract did not enumerate training time, fidelity metrics, or specific clinician backgrounds; those operational implementation details were not reported in the abstract.
The trial produced a null finding for superiority at the primary 16-week endpoint, tempered by maintained gains and an additional OASIS reduction for the MAST group at 28 weeks. Investigators flagged the post hoc moderation by baseline depression as preliminary and in need of prospective replication. The abstract did not report detailed session content, therapist training, attrition rates, or subgroup sample sizes; those details are not available in the abstract and would require full-text review. Future work should prospectively test the moderator hypothesis, measure implementation costs and fidelity, and report granular operational data to clarify which patients are most likely to benefit from a modular Cognitive-behavioral therapy approach in primary care. The study team declared no competing interests.